ProPhase Labs, Inc. — Director's Dealing 2011

Jul 14, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2011-07-12

Reporting Person: GLECKEL LOUIS MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-07-12	Common Stock, par value $0.0005	A	10925	—	Acquired	58915	Direct

Footnotes

F1: These restricted shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan for
Board fees payable to non-employee directors. The 2010 Directors' Equity Compensation Plan was approved by the Company's
stockholders on May 5, 2010.